|
IT1195304B
(it)
|
1981-12-22 |
1988-10-12 |
Anic Spa |
Metodo per la preparazione di gem-diammino derivati n-monoacilati
|
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
US4698327A
(en)
|
1985-04-25 |
1987-10-06 |
Eli Lilly And Company |
Novel glycopeptide derivatives
|
|
IT1190389B
(it)
|
1985-09-19 |
1988-02-16 |
Eniricerche Spa |
Esapeptidi ad attivita' ipotensiva
|
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
|
IT1227907B
(it)
|
1988-12-23 |
1991-05-14 |
Eniricerche S P A Milano Sclav |
Procedimento per la sintesi di peptidi retro-inversi e nuovi intermediin tale procedimento
|
|
US5670617A
(en)
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US6316003B1
(en)
|
1989-12-21 |
2001-11-13 |
Whitehead Institute For Biomedical Research |
Tat-derived transport polypeptides
|
|
US5840313A
(en)
|
1990-09-27 |
1998-11-24 |
Syntello Vaccine Development Kb |
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
|
|
WO1992018138A1
(en)
|
1991-04-10 |
1992-10-29 |
The General Hospital Corporation |
Mammalian gap-43 compositions and methods of use
|
|
US5350835A
(en)
|
1991-11-05 |
1994-09-27 |
Board Of Regents, University Of Texas |
Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
|
|
US5994108A
(en)
|
1991-11-05 |
1999-11-30 |
Board Of Regents, The University Of Texas System |
Mutant TAR virus and transdominant tat mutants as pharmacological agents
|
|
JPH07505283A
(ja)
|
1992-03-20 |
1995-06-15 |
ベイラー・カレッジ・オブ・メディシン |
Ｄｎａトランスポーター系および使用方法
|
|
AU682308C
(en)
|
1992-04-03 |
2006-08-17 |
Regents Of The University Of California, The |
Self-assembling polynucleotide delivery system
|
|
EP0673385A4
(en)
|
1992-08-13 |
1995-11-29 |
Gen Hospital Corp |
COMPOSITIONS CONCERNING GAP-43 MAMMALS AND METHODS OF USE.
|
|
EP0903408A3
(en)
*
|
1992-08-21 |
2005-11-02 |
Biogen, Inc. |
Tat-derived transport polypeptide
|
|
KR950702839A
(ko)
|
1992-08-27 |
1995-08-23 |
스티븐 딕 |
레트로, 인버소-, 및 레트로- 인버소 합성 펩티드 유사체(retro-, inverso-, and retro-inverso synthetic peptide analogues)
|
|
US5545551A
(en)
|
1992-08-28 |
1996-08-13 |
Mt. Sinai School Of Medicine Of The City University Of New York |
Cloning and expression of pur protein
|
|
WO1994023751A1
(de)
|
1993-04-14 |
1994-10-27 |
Boehringer Mannheim Gmbh |
Nukleinsäure-transferpeptide und deren verwendung zur einschleusung von nukleinsäuren in eukaryontische zellen
|
|
EP0679716A4
(en)
|
1993-11-12 |
1999-06-09 |
Kenichi Matsubara |
GENE SIGNATURE.
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
|
JPH10508205A
(ja)
|
1995-04-25 |
1998-08-18 |
バクスター インターナショナル インコーポレイテッド |
肝細胞および膵臓ランゲルハンス島細胞を単離するためのコラーゲナーゼおよびキモパパインを含有する組成物
|
|
AU705563B2
(en)
|
1995-07-28 |
1999-05-27 |
Marie Curie Cancer Care |
Transport proteins and their uses
|
|
AU7366896A
(en)
|
1995-09-21 |
1997-04-09 |
Innapharma, Inc. |
Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras
|
|
IE80466B1
(en)
|
1995-11-10 |
1998-07-29 |
Elan Corp Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
|
US5877282A
(en)
|
1996-09-20 |
1999-03-02 |
Bristol-Myers Squibb Company |
Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
|
|
US6187817B1
(en)
|
1996-10-03 |
2001-02-13 |
Southern Illinois University School Of Medicine |
Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds
|
|
US6361938B1
(en)
|
1996-11-08 |
2002-03-26 |
Elan Corporation, Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
|
WO1998023781A1
(en)
|
1996-11-26 |
1998-06-04 |
Johns Hopkins University |
Ligand detection system and methods of use thereof
|
|
US5989814A
(en)
|
1997-04-01 |
1999-11-23 |
Reagents Of The University Of California |
Screening methods in eucaryotic cells
|
|
US5880261A
(en)
|
1997-04-03 |
1999-03-09 |
Waeber; Gerard |
Transcription factor Islet-Brain 1 (IB1)
|
|
WO1998047913A2
(en)
|
1997-04-18 |
1998-10-29 |
The University Of Medicine And Dentistry Of New Jersey |
Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
|
|
US6043083A
(en)
|
1997-04-28 |
2000-03-28 |
Davis; Roger J. |
Inhibitors of the JNK signal transduction pathway and methods of use
|
|
CA2290756A1
(en)
|
1997-05-15 |
1998-11-19 |
Cytogen Corporation |
Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
|
|
ES2210761T3
(es)
|
1997-05-21 |
2004-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
|
|
FR2767323B1
(fr)
|
1997-08-12 |
2001-01-05 |
Synt Em |
Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
|
|
EP0897002A3
(en)
|
1997-08-14 |
2001-10-04 |
Smithkline Beecham Plc |
U62317, a protein having a JNK-binding domain
|
|
WO1999016787A1
(en)
|
1997-09-26 |
1999-04-08 |
Washington University |
Cell death agonists
|
|
US6420031B1
(en)
|
1997-11-03 |
2002-07-16 |
The Trustees Of Princeton University |
Highly transparent non-metallic cathodes
|
|
HRP20000209A2
(en)
*
|
1997-10-20 |
2001-04-30 |
Hoffmann La Roche |
Bicyclic kinase inhibitors
|
|
US6270956B1
(en)
|
1997-12-11 |
2001-08-07 |
The Salk Institute For Biological Studies |
Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor
|
|
EP0947524A1
(en)
|
1998-03-30 |
1999-10-06 |
Upither B.V. |
Novel peptides for the treatment of autoimmune diseases
|
|
US6248558B1
(en)
|
1998-03-31 |
2001-06-19 |
Vanderbilt University |
Sequence and method for genetic engineering of proteins with cell membrane translocating activity
|
|
CA2330458A1
(en)
|
1998-04-29 |
1999-11-04 |
Georgetown University |
Methods of identifying and using hla binding compounds as hla-agonists and antagonists
|
|
AU4184299A
(en)
|
1998-05-13 |
1999-11-29 |
Incyte Pharmaceuticals, Inc. |
Human apoptosis associated proteins
|
|
US6811992B1
(en)
|
1998-05-14 |
2004-11-02 |
Ya Fang Liu |
Method for identifying MLK inhibitors for the treatment of neurological conditions
|
|
WO1999058561A1
(fr)
|
1998-05-14 |
1999-11-18 |
Pasteur Merieux Serums & Vaccins |
Mimotopes du virus de l'hepatite c
|
|
US6740524B1
(en)
|
1998-06-18 |
2004-05-25 |
Dnavec Research, Inc. |
Nucleic acid transfer phage
|
|
US8038984B2
(en)
|
1998-06-20 |
2011-10-18 |
Washington University |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
JP2002518521A
(ja)
|
1998-06-20 |
2002-06-25 |
ワシントン・ユニバーシティ |
医用画像解析、診断および治療のための膜透過性ペプチド錯体
|
|
US6589503B1
(en)
|
1998-06-20 |
2003-07-08 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
|
DE69914611T2
(de)
|
1998-08-28 |
2004-12-23 |
Gryphon Therapeutics, Inc., South San Francisco |
Verfahren zur herstellung von polyamidketten von genauer länge und deren konjugate mit proteinen
|
|
HK1040053B
(en)
|
1998-09-25 |
2007-09-21 |
Cephalon, Inc. |
Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons
|
|
US20020090696A1
(en)
|
1998-12-08 |
2002-07-11 |
Miller Carol A. |
Treating neurological disorders using human apoptosis inhibiting protein
|
|
US6656474B1
(en)
|
1999-01-15 |
2003-12-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
|
|
US6673908B1
(en)
|
1999-02-22 |
2004-01-06 |
Nuvelo, Inc. |
Tumor necrosis factor receptor 2
|
|
CA2373814A1
(en)
|
1999-05-28 |
2001-02-15 |
Apoptosis Technology, Inc. |
Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
|
|
US7510824B2
(en)
|
1999-06-02 |
2009-03-31 |
Nono Inc. |
Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
|
|
WO2000075118A1
(en)
|
1999-06-03 |
2000-12-14 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK)
|
|
EP1102785B1
(en)
|
1999-06-07 |
2013-02-13 |
Arrowhead Research Corporation |
COMPOSITIONS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES
|
|
WO2001013957A2
(en)
|
1999-08-24 |
2001-03-01 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US20030104622A1
(en)
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
|
AU7473500A
(en)
|
1999-09-01 |
2001-03-26 |
University Of Pittsburgh |
Identification of peptides that facilitate uptake and cytoplasmic and/or nucleartransport of proteins, dna and viruses
|
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US20030108539A1
(en)
|
2000-02-14 |
2003-06-12 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US6610820B1
(en)
|
1999-10-12 |
2003-08-26 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US20010046489A1
(en)
|
1999-12-06 |
2001-11-29 |
Habener Joel E. |
Stem cells of the islets of langerhans and their use in treating diabetes mellitus
|
|
AU783110B2
(en)
|
1999-12-16 |
2005-09-22 |
Biogen Ma Inc. |
Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
|
|
EP1294746B1
(en)
|
2000-06-16 |
2011-05-04 |
Serodus AS |
Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
|
|
US6586403B1
(en)
|
2000-07-20 |
2003-07-01 |
Salpep Biotechnology, Inc. |
Treating allergic reactions and inflammatory responses with tri-and dipeptides
|
|
US6897231B2
(en)
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
|
US7033597B2
(en)
|
2000-10-13 |
2006-04-25 |
Université de Lausanne |
Intracellular delivery of biological effectors
|
|
CA2425610A1
(en)
|
2000-10-13 |
2002-04-18 |
University Of Lausanne |
Intracellular delivery of biological effectors by novel transporter peptide sequences
|
|
AU1112202A
(en)
|
2000-10-17 |
2002-04-29 |
Diatranz Ltd |
Preparation and xenotransplantation or porcine islets
|
|
US20030077826A1
(en)
|
2001-02-02 |
2003-04-24 |
Lena Edelman |
Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
|
|
WO2002062792A1
(en)
|
2001-02-02 |
2002-08-15 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
|
AU2002240312A1
(en)
|
2001-02-08 |
2002-08-19 |
Pankaj Paranjp |
Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates
|
|
DE60233137D1
(de)
|
2001-02-16 |
2009-09-10 |
Univ R |
Transporter mit beabstandeten arginin-teilchen
|
|
AU2002307229B2
(en)
|
2001-04-06 |
2007-05-24 |
Thomas Jefferson University |
Multimerization of HIV-1 Vif protein as a therapeutic target
|
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
|
US20060216706A1
(en)
|
2001-07-17 |
2006-09-28 |
Tang Y T |
Proteins associated with cell growth, differentiation, and death
|
|
CN100391958C
(zh)
|
2001-09-19 |
2008-06-04 |
安万特医药股份有限公司 |
化合物
|
|
US7635681B2
(en)
|
2002-01-09 |
2009-12-22 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
NZ535349A
(en)
|
2002-03-08 |
2007-01-26 |
Signal Pharm Inc |
JNK inhibitors with chemotherapeutic agents in a combination therapy for treating or preventing cancer and other proliferative disorders in refractory patients in particular
|
|
US20040034084A1
(en)
*
|
2002-05-24 |
2004-02-19 |
Celgene Corporation |
Methods for using JNK inhibitors for treating or preventing disease-related wasting
|
|
MXPA04011851A
(es)
*
|
2002-05-30 |
2005-03-31 |
Celgene Corp |
Metodos para utilizar inhibidores de jnk o mkk para modular diferenciacion de celula y para tratar desordenes mieloproliferativos y sindromes mielodispl??sticos.
|
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
|
JP2004066595A
(ja)
|
2002-08-05 |
2004-03-04 |
Canon Finetech Inc |
記録装置およびレジストレーション用パターンの記録方法
|
|
JP2006502183A
(ja)
|
2002-09-20 |
2006-01-19 |
アルコン，インコーポレイテッド |
ドライアイ障害の処置のためのサイトカイン合成インヒビターの使用
|
|
EP1408114B1
(de)
|
2002-10-11 |
2007-01-03 |
Imvision GmbH |
Moduläre Antigen-Transporter Moleküle (MAT-Moleküle) zur Modulierung von Immunreaktionen, zugehörige Konstrukte, Verfahren und Verwendungen
|
|
ZA200503242B
(en)
*
|
2002-10-24 |
2006-10-25 |
Celgene Corp |
Treatment of pain with JNK inhibitors
|
|
AU2003286611A1
(en)
*
|
2002-10-24 |
2004-05-13 |
Sangstat Medical Corporation |
Cytomodulating peptides and methods for treating neurological disorders
|
|
US20050019366A1
(en)
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
|
US7166692B2
(en)
|
2003-03-04 |
2007-01-23 |
Canbrex Bio Science Walkersville, Inc. |
Intracellular delivery of small molecules, proteins, and nucleic acids
|
|
US7432375B2
(en)
|
2003-03-06 |
2008-10-07 |
Eisai R & D Management Co., Ltd. |
JNK inhibitors
|
|
AU2004235396B2
(en)
|
2003-04-29 |
2010-11-25 |
Sarepta Therapeutics, Inc. |
Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
|
|
US20050048995A1
(en)
|
2003-08-25 |
2005-03-03 |
Motorola, Inc. |
System and method for controlling the operating characteristics of a buffer
|
|
KR100685345B1
(ko)
|
2004-03-27 |
2007-02-22 |
학교법인조선대학교 |
세포사 유도 펩타이드
|
|
JP5080241B2
(ja)
|
2004-04-08 |
2012-11-21 |
メルク セローノ ソシエテ アノニム |
Ｊｎｋ阻害剤およびスクロスポリンを含んでなる組成物
|
|
CA2578122A1
(en)
|
2004-08-27 |
2006-03-02 |
Gpc Biotech Ag |
Pyrimidine derivatives
|
|
US7803824B2
(en)
*
|
2004-10-29 |
2010-09-28 |
Alcon, Inc. |
Use of inhibitors of Jun N-terminal kinases to treat glaucoma
|
|
US20060094753A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Alcon, Inc. |
Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
|
|
EP1656951A1
(en)
|
2004-11-12 |
2006-05-17 |
Xigen S.A. |
Conjugates with enhanced cell uptake activity
|
|
US20100256041A1
(en)
|
2004-11-12 |
2010-10-07 |
Christophe Bonny |
Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
|
|
EP1661912A1
(en)
|
2004-11-29 |
2006-05-31 |
Xigen S.A. |
Fusion protein comprising a BH3-domain of a BH3-only protein
|
|
EP1676574A3
(en)
*
|
2004-12-30 |
2006-07-26 |
Johnson & Johnson Vision Care, Inc. |
Methods for promoting survival of transplanted tissues and cells
|
|
CN101142215A
(zh)
*
|
2005-01-13 |
2008-03-12 |
西格诺药品有限公司 |
卤代芳基取代的氨基嘌呤、其组合物及其治疗方法
|
|
US20060223807A1
(en)
|
2005-03-29 |
2006-10-05 |
University Of Massachusetts Medical School, A Massachusetts Corporation |
Therapeutic methods for type I diabetes
|
|
US20070015779A1
(en)
|
2005-04-29 |
2007-01-18 |
John Griffin |
Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
|
|
ZA200709240B
(en)
|
2005-04-29 |
2009-06-24 |
Celgene Corp |
Solid forms of 1-(5-(IH-1,2,4-triazol-5-yl)(IH-indazol-3-yl)-3-(2-piperidylethoxy)benzene
|
|
US20070003531A1
(en)
|
2005-06-30 |
2007-01-04 |
University Of Connecticut |
Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes
|
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
WO2008006046A1
(en)
|
2006-07-06 |
2008-01-10 |
Case Western Reserve University |
Ceramide composition and use thereof in treatment of ocular diseases
|
|
EP1884521A1
(en)
|
2006-07-31 |
2008-02-06 |
Xigen S.A. |
Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins
|
|
WO2008094208A2
(en)
|
2006-08-02 |
2008-08-07 |
Northwestern University |
Protein kinase targeted therapeutics
|
|
KR101177729B1
(ko)
|
2006-09-08 |
2012-09-07 |
에프. 호프만-라 로슈 아게 |
벤조트리아졸 키나아제 조절제
|
|
CA2663545A1
(en)
|
2006-09-19 |
2008-03-27 |
Phylogica Limited |
Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof
|
|
GB0702259D0
(en)
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
|
MX2010011880A
(es)
|
2008-04-29 |
2011-05-25 |
Pharnext |
Nuevos enfoques terapeuticos para tratar la enfermedad del alzheimer y trastornos relacionados mediante una modulacion de la respuesta de estres celular.
|
|
HRP20150097T1
(hr)
|
2008-05-07 |
2015-03-27 |
The Regents Of The University Of California |
Terapijska nadopuna i poboljšanje vlaženja površine oka
|
|
WO2009143865A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
|
US20100183633A1
(en)
*
|
2008-12-04 |
2010-07-22 |
University Of Massachusetts |
Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition
|
|
WO2010072228A1
(en)
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
|
WO2010073104A2
(en)
|
2008-12-23 |
2010-07-01 |
Carmel - Haifa University Economic Corp Ltd. |
Improving cognitive function
|
|
AU2010210426B2
(en)
|
2009-02-06 |
2015-06-11 |
Imago Pharmaceuticals, Inc. |
Inhibitors of Jun N-terminal kinase
|
|
EA201171188A1
(ru)
|
2009-03-30 |
2012-05-30 |
Сантен Фармасьютикал Ко., Лтд. |
Профилактическое или терапевтическое средство против болезни сетчатки и способ профилактики или лечения болезни сетчатки с использованием jnk (c-jun-аминоконцевая киназа)-ингибиторного пептида, а также применение указанного пептида
|
|
IN2012DN01231A
(enExample)
*
|
2009-08-10 |
2015-05-15 |
Hoffmann La Roche |
|
|
SG10201406763WA
(en)
|
2009-10-22 |
2014-11-27 |
Genentech Inc |
Modulation of axon degeneration
|
|
EP2519249A4
(en)
|
2009-12-31 |
2013-06-26 |
Stealth Peptides Int Inc |
METHOD FOR CARRYING OUT A CORONARY ARTERY BYPASS PROCEDURE
|
|
BR112012030814A2
(pt)
*
|
2010-06-04 |
2019-09-24 |
Hoffmann La Roche |
inibidores de jnk
|
|
WO2011160653A1
(en)
*
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
|
EP2627346B1
(en)
|
2010-10-14 |
2016-03-23 |
Xigen Inflammation Ltd. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway for use in the treatment of uveitis
|
|
AU2010362444B2
(en)
|
2010-10-14 |
2015-08-06 |
Xigen Inflammation Ltd. |
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
|
US8471027B2
(en)
*
|
2011-04-06 |
2013-06-25 |
Hoffmann-La Roche Inc. |
Adamantyl compounds
|
|
WO2013079213A1
(en)
|
2011-11-30 |
2013-06-06 |
Xigen Inflammation Ltd. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome
|
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
|
WO2015197193A2
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
EA201501080A1
(ru)
|
2013-06-26 |
2016-07-29 |
Ксижен Инфлемейшн Лтд. |
Новое применение обладающих способностью проникать в клетку пептидных ингибиторов пути трансдукции сигнала jnk для лечения различных заболеваний
|
|
WO2014206426A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
JP2015197193A
(ja)
|
2014-04-02 |
2015-11-09 |
トヨタ自動車株式会社 |
車両用無段変速機の油圧制御装置
|
|
EP3313428A1
(en)
|
2015-06-26 |
2018-05-02 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of mild cognitive impairment
|